Selected Toxicities of Targeted Therapies: Presentation and Management

被引：7
|
作者：
Kollmannsberger, Christian [1 ]
Mitchell, Teresa [1 ]
机构：
[1] British Columbia Canc Agcy, Vancouver Canc Ctr, Div Med Oncol, Vancouver, BC V5Z 4E6, Canada
来源：
SEMINARS IN ONCOLOGY | 2013年 / 40卷 / 04期
关键词：
RENAL-CELL CARCINOMA; ENDOTHELIAL GROWTH-FACTOR; INTERFERON-ALPHA; FACTOR RECEPTOR; SUNITINIB; EFFICACY; HYPERTENSION; EVEROLIMUS; TEMSIROLIMUS; BEVACIZUMAB;
D O I：
10.1053/j.seminoncol.2013.05.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The introduction of targeted therapy has changed the landscape of metastatic renal cell carcinoma (mRCC) but has also brought challenges. One such challenge of treating this chronic disease is long-term therapy, which produces ongoing toxicity. Knowledge of the spectrum of toxicity from targeted therapy and appropriate and timely intervention is required to maintain adequate dosing required for optimal outcome. This article addresses some of the major toxicities of newer agents in RCC and discusses management strategies. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码：499 / 510
页数：12
相关论文
共 50 条
  • [1] Toxicities of targeted therapies and their management in renal cancer: methodology of guidelines
    Escudier, Bernard
    Joly, Florence
    Soria, Jean-Charles
    BULLETIN DU CANCER, 2011, 98 : S3 - S6
  • [2] Treatment-Associated Adverse Event Management in the Advanced Renal Cell Carcinoma Patient Treated with Targeted Therapies
    Ravaud, Alain
    ONCOLOGIST, 2011, 16 : 32 - 44
  • [3] Practical management of toxicities associated with targeted therapies for advanced gastroenteropancreatic neuroendocrine tumors
    Cuyle, Pieter-Jan
    Prenen, Hans
    ANNALS OF GASTROENTEROLOGY, 2018, 31 (02): : 140 - 150
  • [4] Renal Toxicities of Targeted Therapies
    Abbas, Anum
    Mirza, Mohsin M.
    Ganti, Apar Kishor
    Tendulkar, Ketki
    TARGETED ONCOLOGY, 2015, 10 (04) : 487 - 499
  • [5] Advances in the Management of Cutaneous Toxicities of Targeted Therapies
    Robert, Caroline
    Sibaud, Vincent
    Mateus, Christine
    Cherpelis, Basil S.
    SEMINARS IN ONCOLOGY, 2012, 39 (02) : 227 - 240
  • [6] Toxicities of Targeted Therapy and Their Management in Kidney Cancer
    Di Lorenzo, Giuseppe
    Porta, Camillo
    Bellmunt, Joaquim
    Sternberg, Cora
    Kirkali, Ziya
    Staehler, Michael
    Joniau, Steven
    Montorsi, Francesco
    Buonerba, Carlo
    EUROPEAN UROLOGY, 2011, 59 (04) : 526 - 540
  • [7] Management of metastatic renal cell carcinoma in the era of targeted therapies
    Webber, K.
    Cooper, A.
    Kleiven, H.
    Yip, D.
    Goldstein, D.
    INTERNAL MEDICINE JOURNAL, 2011, 41 (08) : 594 - 605
  • [8] Management of targeted molecular therapies toxicities in thoracic cancerology
    Rajpar, S.
    Osio, A.
    Besse, B.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2008, 64 (02) : 104 - 110
  • [9] Renal Toxicities of Targeted Therapies
    Anum Abbas
    Mohsin M. Mirza
    Apar Kishor Ganti
    Ketki Tendulkar
    Targeted Oncology, 2015, 10 : 487 - 499
  • [10] A contemporary update on rates and management of toxicities of targeted therapies for metastatic renal cell carcinoma
    Alasker, Ahmed
    Meskawi, Malek
    Sun, Maxine
    Ismail, Salima
    Hanna, Nawar
    Hansen, Jens
    Tian, Zhe
    Bianchi, Marco
    Perrotte, Paul
    Karakiewicz, Pierre I.
    CANCER TREATMENT REVIEWS, 2013, 39 (04) : 388 - 401
12345